Special Issue “Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies”

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Translating molecular insights may improve diagnosis and treatment of neuropsychiatric conditions like depression and schizophrenia.

Novel biomarkers enhance diagnosis and treatment of neuropsychiatric conditions, including depression and schizophrenia.
Evidence indicates a shift towards personalized therapies for better patient outcomes in mental health.
Review highlights advancements in understanding molecular factors associated with dementia and other conditions.
Implications suggest that embracing molecular psychiatry can lead to more effective, tailored interventions.

Masaru Tanaka (2025) studied this question.

View Full Paper

Ask AI

Bookmark